We believe this site might serve you best:

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

GloSensor™ Technology

E1290

Live-Cell Biosensors for cAMP, cGMP or Protease Activity

  • Biosensors enable more complete analysis of receptor biology
  • Simple, scalable assay protocol
  • High Z´ and large signal:background ratio

Choose a product

Size

Catalog number selected: E1290

$ 402.00 Your price: Log In

GloSensor™ Technology
Assay Reagent/25mg
$ 402.00
Your price: Log In
Change Configuration

Luciferase Biosensor for Real-Time Detection of Signaling Events

GloSensor™ technology provides a platform of flexible luciferase-based biosensors for real-time detection of signaling events in live cells with sensitivity, linearity and specificity.

GloSensor™ luciferase is circularly permuted, joining the wild-type N- and C-termini with a polypeptide or protein domain and creating engineered termini elsewhere within the structure. Analyte binding or protease cleavage leads to a conformational shift in the biosensor that promotes large increases in luminescence activity. The magnitude of the luminescence increase is directly proportional to the amount of analyte or protease activity present.

12765TA_600px

Simple, Scalable, Live-Cell Protocol

GloMaxDiscover_1280x1215 multimode plate reader

The live-cell, non-lytic assay protocol is easy to perform, allowing biosensor activity to be monitored continuously or at a single time point. The kinetic profile of cell signaling events can be followed in real time and the assays easily scale to high-density microplate formats, including 96-, 384- and 1536-well plates.

The protocol steps are:

  • Pre-equilibrate cells with GloSensor™ cAMP Reagent for ~2 hours.

  • Treat with specific agonists/antagonists or library compounds.

  • Measure luminescence after 10–30 minutes either continuously or at a single time point.

Any luminometer with injectors is sufficient to read the assay.

Perform cAMP, cGMP or Protease Assays

cAMP Assay
cGMP Assay
Protease Assay

Monitor Intracellular cAMP in a Live-Cell Assay

The GloSensor™ cAMP Assay can be used to monitor activation of endogenous or overexpressed Gs- or Gi-coupled 7-TM, G-protein coupled receptors (GPCRs), together with phosphodiesterases (PDEs) that are responsible for degrading intracellular cAMP. Intracellular changes in cAMP concentration can be followed using a live-cell, non-lytic assay format, allowing real-time monitoring of changes in cAMP concentration.

Different biosensors are available for use in the GloSensor™ cAMP Assay. In each case, a cAMP binding domain is fused to a circularly permuted form of firefly luciferase. The sequence for each differs, giving biosensors with a range of affinities for cAMP. In general, the pGloSensor™-22F cAMP Plasmid is best-suited for most applications, providing a unique combination of sensitivity and dynamic range. The 22F construct is sensitive enough to monitor inverse agonist activity or Gi-coupled receptor activation in the absence of added forskolin, but possess a large enough dynamic range to monitor very large increases in intracellular cAMP concentration.

12766MA_600px
Kinetic response of GloSensor™ cAMP compared to a cAMP immunoassay. HEK293 cells transiently expressing the pGloSensor™-22F cAMP Plasmid were treated sequentially with 1 µM isoproterenol (ISO), 10 µM propranolol (PRO), and 10 µM forskolin (FSK). The live-cell, non-lytic GloSensor™ cAMP Assay protocol was used to monitor cAMP levels, whereas replicate wells were lysed at each time point for the cAMP immunoassay (Enzo Life Sciences). Samples above approximately 20 nM required dilution for the cAMP immunoassay to be within the linear range of the standard curve. (ISO = ADRB2 agonist, PRO = ADRB2 antagonist, FSK = cell permeable activator of adenylyl cyclase). 

Monitor Intracellular cGMP in a Live-Cell Assay

The GloSensor™ cGMP Assay is used to monitor changes in the intracellular concentration of the second messenger cGMP. The assay can be used to monitor activation of endogenous or overexpressed guanylyl cyclases, including soluble guanylyl cyclase (sGC) or atrial natriuretic peptide receptor (NPRA and NPRB) isoforms, together with the phosphodiesterases (PDEs) that are responsible for degrading intracellular cGMP. Intracellular changes in cGMP concentration can be followed using a live-cell, non-lytic assay format, allowing real-time monitoring of changes in cGMP concentration.

Different biosensors are available for use in the GloSensor™ cGMP Assay. In each case, a cGMP binding domain is fused to a circularly permuted form of firefly luciferase. The cGMP binding domain and sequence for each differs, giving biosensors with different affinities for cGMP. In general, the 40F construct is preferred when overexpressing a guanylyl cyclase, providing maximal dynamic range at high intracellular levels of cGMP. In contrast, the 42F construct is preferred when assaying an endogenous guanylyl cyclase, providing maximal sensitivity for lower intracellular levels of cGMP.

Order cGMP Assay
12767MA_600px
Real-time cGMP monitoring. HEK293 cells transiently expressing the 42F construct were treated with varying doses of sodium nitroprusside (SNP), a nitric oxide donor, to activate the endogenous soluble guanylyl cyclase (sGC). The live-cell, non-lytic GloSensor™ cAMP Assay protocol was used to monitor the cGMP response in real-time.

Luminescent Detection of Protease Activity

The GloSensor™ Protease Assay is used to monitor protease activity both in vitro and in vivo. The approach utilizes circularly permuted forms of luciferase where the wild-type N- and C-termini are tethered with a peptide containing a protease cleavage site. Once cleaved by the corresponding protease, a conformational constraint is lifted, resulting in large increases in luminescence activity. Peptides containing protease cleavage sites up to 20 amino acids in length have been validated in vitro, using this technology, including proteases that require P’ residues for efficient cleavage. 

A novel GloSensor™ protease construct, the 30F plasmid, was developed for live-cell, non-lytic assays of protease activity for use in both cell culture and in vivo models. When engineered with a caspase-3/7 cleavage site, the GloSensor™ caspase 3/7 biosensor enables a sensitive, real-time approach for the detection of caspase-3/7 activity enabling a method for in vivo measure of apoptosis in animal models. The GloSensor™ caspase 3/7 biosensor, together with a similar construct designed to detect granzyme B, have also been used for the detection of target cell apoptosis mediated by in vitro-derived or ex vivo cytotoxic T lymphocytes (CTLs). You can read more about this work in this work in the article: A real-time assay of caspase-3/7 activity in cell culture and animal models.

The GloSensor™ caspase 3/7 biosensor plasmid, stable cells lines and granzyme biosensor plasmids are available as custom assay materials. These biosensor plasmids can be used directly or modified by the insertion of novel cleavage sites to create biosensors for a particular protease of interest.

Order Protease Assay

GloSensor™ Plasmids

We offer two variants of the biosensor, and we recommend the pGloSensor™-22F cAMP Plasmid as the first choice for most applications.

pGloSensor™-22F cAMP Plasmid. Following cell-free expression in vitro, the version encoded by this construct shows an increased EC50 for activation together with increased signal-to-background ratio at cAMP saturation relative to the version encoded by the pGloSensor™-20F cAMP construct. In general, we have observed similar relationships between the two constructs when their performance is compared in living cells.

pGloSensor™-20F cAMP Plasmid. The version encoded by this construct performs well in HEK293 cells at 37°C. Luminescence from the pGloSensor™-22F cAMP Plasmid construct can be more difficult to detect at physiologic temperatures.

For a thorough explanation of the performance differences between the two plasmids, please consult Section 3.B, Recommendations on Choice of GloSensor™ Plasmid, in Technical Manual #TM076 (provided in the Protocol Section below).

pGloSensor-22F cAMP Plasmid.
pGloSensor™-20F cAMP, Accession Number EU770615Sequence (.txt file)
pGloSensor™-22F cAMP, Accession Number GU174434; Sequence (.txt file)

Specifications

You are viewing: E1290 Change Configuration

What's in the box?

Item Part # Size

GloSensor™ cAMP Reagent

E129A 1 × 25mg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

AA

See Protocol for detailed storage recommendations.

Specifications

You are viewing: E1291 Change Configuration

What's in the box?

Item Part # Size

GloSensor™ cAMP Reagent

E129B 1 × 250mg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

AA

See Protocol for detailed storage recommendations.

Specifications

You are viewing: E2301 Change Configuration

What's in the box?

Item Part # Size

pGloSensor™-22F cAMP Plasmid

E230A 1 × 20μg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

See Protocol for detailed storage recommendations.

Patents and Disclaimers

BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researchers may use this product in their own research solely for the luminescent determination of molecular binding, enzymatic activity or other functional activity. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence encoding the GloSensor™ technology of this product (i.e., the bioluminescent chimeric protein comprising luciferase and other functional domains). Researchers may transfer derivatives to others provided that recipients agree to be bound by the terms of this label license prior to such transfer. No other use or transfer of this product is authorized without the prior express written consent of Promega. In addition, researchers must either: (1) use GloSensor™ cAMP Reagent for in vitro and in cell applications, and VivoGlo™ Luciferin, In Vivo Grade, for animal applications for all determinations of luminescence activity of this product and derivatives; or (2) contact Promega to obtain a license for use of the product and derivatives in conjunction with luminescent assay reagents not purchased from Promega. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Patent Pending.

U.S. Pat. No. 8,008,006 and European Pat. No. 1341808.

U.S. Pat. No. 7,728,118 and other patents pending.

Specifications

You are viewing: E1171 Change Configuration

What's in the box?

Item Part # Size

pGloSensor™-20F cAMP Plasmid

E117A 1 × 20μg

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

See Protocol for detailed storage recommendations.

Patents and Disclaimers

BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researchers may use this product in their own research solely for the luminescent determination of molecular binding, enzymatic activity or other functional activity. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence encoding the GloSensor™ technology of this product (i.e., the bioluminescent chimeric protein comprising luciferase and other functional domains). Researchers may transfer derivatives to others provided that recipients agree to be bound by the terms of this label license prior to such transfer. No other use or transfer of this product is authorized without the prior express written consent of Promega. In addition, researchers must either: (1) use GloSensor™ cAMP Reagent for in vitro and in cell applications, and VivoGlo™ Luciferin, In Vivo Grade, for animal applications for all determinations of luminescence activity of this product and derivatives; or (2) contact Promega to obtain a license for use of the product and derivatives in conjunction with luminescent assay reagents not purchased from Promega. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Patent Pending.

U.S. Pat. No. 8,008,006 and European Pat. No. 1341808.

U.S. Pat. No. 7,728,118 and other patents pending.

Specifications

You are viewing: E1261 Change Configuration

What's in the box?

Item Part # Size

GloSensor™ cAMP HEK293 Cell Line

E126A 2 × 1 vial

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

XX

See Protocol for detailed storage recommendations.

Patents and Disclaimers

BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researchers may use this product in their own research solely for the luminescent determination of molecular binding, enzymatic activity or other functional activity. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence encoding the GloSensor™ technology of this product (i.e., the bioluminescent chimeric protein comprising luciferase and other functional domains). Researchers may transfer derivatives to others provided that recipients agree to be bound by the terms of this label license prior to such transfer. No other use or transfer of this product is authorized without the prior express written consent of Promega. In addition, researchers must either: (1) use GloSensor™ cAMP Reagent for in vitro and in cell applications, and VivoGlo™ Luciferin, In Vivo Grade, for animal applications for all determinations of luminescence activity of this product and derivatives; or (2) contact Promega to obtain a license for use of the product and derivatives in conjunction with luminescent assay reagents not purchased from Promega. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.

Commercial use of this cell line requires a license from AdVec Inc.

Use of Genetically Modified Microorganisms (GMM)
Information for European Customers: These products are genetically modified as described in Promega technical literature. As a condition of sale, use of this product must be in accordance with all applicable local guidelines on the contained use of genetically modified microorganisms, including the Directive 2009/41/EC of the European Parliament and of the Council.

HEK293 cells were obtained under license from AdVec Inc.

workflow-background
Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom